STAHL NEIL — SEC Form 4 filings
SEC reporting owner CIK 1226689. 8 Form 4 filings on record with FilingPulse; latest filed 2024-12-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-06 to 2024-12-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 2 filings — 13,234 shares, $13,274,300 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 3,127 shares @ $950.43 ($2,971,995) in REGENERON PHARMACEUTICALS, INC., filed 2024-02-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Research and Development | 8 | — | 13 legs · 13,234 sh · $13,274,300 | 11 |
Form 4 filings — STAHL NEIL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 304 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 466 @ $787 | EDGAR |
| 2024-08-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 500 @ $0 | EDGAR |
| 2024-08-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 100 @ $1,081.83 · Sale (S): 200 @ $1,082.69 · Sale (S): 1,006 @ $1,083.76 · Sale (S): 1,883 @ $1,084.61 · Sale (S): 1,708 @ $1,085.01 · Sale (S): 300 @ $1,086.15 · +1 more | EDGAR |
| 2024-08-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 23,638 @ $555.67 · Tax withholding (F): 18,441 @ $1,093.49 · Option exercise (M): 23,638 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,020 @ $0 | EDGAR |
| 2024-02-08 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 100 @ $947.34 · Sale (S): 1,894 @ $948.69 · Sale (S): 601 @ $949.45 · Sale (S): 3,127 @ $950.43 · Sale (S): 1,237 @ $951.49 · Sale (S): 1,059 @ $952.49 · +1 more | EDGAR |
| 2024-02-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 30,750 @ $399.66 · Tax withholding (F): 22,713 @ $956.65 · Option exercise (M): 30,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1226689 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →